A method for the treatment and/or prophylaxis of a neurological and/or neuropsychiatric disorder associated with altered dopamine function comprising administering to the eye of a patient in need thereof an effective amount of an agent that modulates neurotransmitter production or function.
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 31/165 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide
A61K 31/4515 - Pipéridines non condensées, p. ex. pipérocaïne ayant un groupe butyrophénone en position 1, p. ex. halopéridol
A61K 31/454 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'azote comme hétéro-atome du cycle, p. ex. pimozide, dompéridone
A61K 31/5415 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec au moins un azote et au moins un soufre comme hétéro-atomes d'un cycle, p. ex. sulthiame condensés en ortho ou en péri avec des systèmes carbocycliques, p. ex. phénothiazine, chlorpromazine, piroxicam
Medical devices, namely, portable light units for use in the
fields of light therapy and light supplementation for
neurological disorders; medical devices, namely, portable
light units for use in the field of light therapy for
neurological disorders; light boxes for providing light
therapy for neurological disorders; portable ocular light
therapy apparatuses for the treatment of symptoms of
neurological disorders; portable ocular light therapy
apparatuses for the treatment of neurological disorders;
portable ocular light therapy apparatuses for the treatment
of symptoms of motor-related neurological disorders;
portable ocular light therapy apparatuses for the treatment
of motor-related neurological disorders; portable ocular
light therapy apparatuses for the treatment of symptoms of
Parkinson's disease; portable ocular light therapy
apparatuses for the treatment of Parkinson's disease.
Medical devices, namely, portable light units for use in the
fields of light therapy and light supplementation for
neurological disorders; medical devices, namely, portable
light units for use in the field of light therapy for
neurological disorders; light boxes for providing light
therapy for neurological disorders; portable ocular light
therapy apparatuses for the treatment of symptoms of
neurological disorders; portable ocular light therapy
apparatuses for the treatment of neurological disorders;
portable ocular light therapy apparatuses for the treatment
of symptoms of motor-related neurological disorders;
portable ocular light therapy apparatuses for the treatment
of motor-related neurological disorders; portable ocular
light therapy apparatuses for the treatment of symptoms of
Parkinson's disease; portable ocular light therapy
apparatuses for the treatment of Parkinson's disease.
4.
METHODS FOR PREVENTING AND TREATING MOTOR-RELATED NEUROLOGICAL CONDITIONS
Methods for preventing or treating motor-related neurological conditions include using ocular light therapy in connection with a conventional therapy for a motor-related neurological condition, such as a drug regimen, to adjust levels of melatonin and/or dopamine in the body of a subject. The ocular light therapy may include elevated levels of blue-green light or green light (e.g., light within a wavelength range of 460 nm to 570 nm, 490 nm to 570 nm, about 520 nm to 570 nm, etc.). The ocular light therapy may also include reduced levels of amber, orange and/or red light. Methods for diagnosing motor-related neurological conditions include use of ocular light therapy to cause a subject to temporarily exhibit one or more symptoms of any motor-related neurological condition to which the subject is predisposed, or which the subject may already be experiencing. A temporary increase in such symptoms may be effected by ocular administration of light including increased amounts of amber, orange and/or red light.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61N 5/06 - Thérapie par radiations utilisant un rayonnement lumineux
A61M 21/00 - Autres dispositifs ou méthodes pour amener un changement dans l'état de conscienceDispositifs pour provoquer ou arrêter le sommeil par des moyens mécaniques, optiques ou acoustiques, p. ex. pour mettre en état d'hypnose
Medical devices, namely, portable light units for use in the fields of light therapy and light supplementation for neurological disorders; medical devices, namely, portable light units for use in the field of light therapy for neurological disorders; light boxes for providing light therapy for neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of neurological disorders; portable ocular light therapy apparatuses for the treatment of neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of Parkinson's disease; portable ocular light therapy apparatuses for the treatment of Parkinson's disease
Medical devices, namely, portable light units for use in the fields of light therapy and light supplementation for neurological disorders; medical devices, namely, portable light units for use in the field of light therapy for neurological disorders; light boxes for providing light therapy for neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of neurological disorders; portable ocular light therapy apparatuses for the treatment of neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of Parkinson's disease; portable ocular light therapy apparatuses for the treatment of Parkinson's disease
Medical devices, namely, portable light units for use in the fields of light therapy and light supplementation for neurological disorders; medical devices, namely, portable light units for use in the field of light therapy for neurological disorders; light boxes for providing light therapy for neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of neurological disorders; portable ocular light therapy apparatuses for the treatment of neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of Parkinson's disease; portable ocular light therapy apparatuses for the treatment of Parkinson's disease
8.
Ocular treatments for neurological and neuropsychiatric disorders
A method for the treatment and/or prophylaxis of a neurological and/or neuropsychiatric disorder associated with altered dopamine function comprising administering to the eye of a patient in need thereof an effective amount of an agent that modulates neurotransmitter production or function.
A61K 31/165 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide
A61K 31/4515 - Pipéridines non condensées, p. ex. pipérocaïne ayant un groupe butyrophénone en position 1, p. ex. halopéridol
A61K 31/454 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'azote comme hétéro-atome du cycle, p. ex. pimozide, dompéridone
A61K 31/5415 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec au moins un azote et au moins un soufre comme hétéro-atomes d'un cycle, p. ex. sulthiame condensés en ortho ou en péri avec des systèmes carbocycliques, p. ex. phénothiazine, chlorpromazine, piroxicam
Methods for preventing or treating motor-related neurological conditions include using ocular light therapy in connection with a conventional therapy for a motor-related neurological condition, such as a drug regimen, to adjust levels of melatonin and/or dopamine in the body of a subject. The ocular light therapy may include elevated levels of blue-green light or green light (e.g., light within a wavelength range of 460 nm to 570 nm, 490 nm to 570 nm, about 520 nm to 570 nm, etc.). The ocular light therapy may also include reduced levels of amber, orange and/or red light. Methods for diagnosing motor-related neurological conditions include use of ocular light therapy to cause a subject to temporarily exhibit one or more symptoms of any motor-related neurological condition to which the subject is predisposed, or which the subject may already be experiencing. A temporary increase in such symptoms may be effected by ocular administration of light including increased amounts of amber, orange and/or red light.
Medical devices, namely, portable light units for use in the
fields of light therapy and light supplementation; medical
devices, namely, portable light units for use in the field
of light therapy; light boxes for providing light therapy
for medical purposes; portable ocular light therapy
apparatuses for the treatment of symptoms of motor-related
neurological disorders; portable ocular light therapy
apparatuses for the treatment of motor-related neurological
disorders; portable ocular light therapy apparatuses for the
treatment of symptoms of Parkinson's disease; portable
ocular light therapy apparatuses for the treatment of
Parkinson's disease.
Medical devices, namely, portable light units for use in the fields of light therapy and light supplementation for motor-related neurological disorders; medical devices, namely, portable light units for use in the field of light therapy for motor- related neurological disorders; light boxes for providing light therapy for motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of motor-related neurological disorders; portable ocular light therapy apparatuses for the treatment of symptoms of Parkinson's disease; portable ocular light therapy apparatuses for the treatment of Parkinson's disease
12.
Methods for preventing and treating motor related neurological conditions
Methods for preventing or treating motor-related neurological conditions include using ocular light therapy in connection with a conventional therapy for a motor-related neurological condition, such as a drug regimen, to adjust levels of melatonin and/or dopamine in the body of a subject. The ocular light therapy may include elevated levels of blue-green light or green light (e.g., light within a wavelength range of 460 nm to 570 nm, 490 nm to 570 nm, about 520 nm to 570 nm, etc.). The ocular light therapy may also include reduced levels of amber, orange and/or red light. Methods for diagnosing motor-related neurological conditions include ocular administration of increased amounts of amber, orange and/or red light to cause a subject to temporarily exhibit one or more symptoms of any motor-related neurological condition to which the subject is predisposed, or which the subject may already be experiencing.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
A61N 5/06 - Thérapie par radiations utilisant un rayonnement lumineux
A61M 21/00 - Autres dispositifs ou méthodes pour amener un changement dans l'état de conscienceDispositifs pour provoquer ou arrêter le sommeil par des moyens mécaniques, optiques ou acoustiques, p. ex. pour mettre en état d'hypnose
A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
A61B 5/16 - Dispositifs pour la psychotechnieTest des temps de réaction
G06K 9/00 - Méthodes ou dispositions pour la lecture ou la reconnaissance de caractères imprimés ou écrits ou pour la reconnaissance de formes, p.ex. d'empreintes digitales
13.
APPARATUSES FOR TREATING AND/OR DIAGNOSING MOTOR-RELATED NEUROLOGICAL CONDITIONS
Light therapy apparatuses are configured to expose a subject to light that is tailored to address and/or diagnose at least one motor-related neurological condition. Blue-green light and green light are useful for treating motor-related neurological conditions or their symptoms. Deep red light and near infrared radiation may facilitate the repair of retinal cells and/or neurons that may be responsible for motor-related neurological conditions. Amber, orange and red light enable the early diagnosis of motor-related neurological conditions.
Light therapy apparatuses are configured to expose a subject to light that is tailored to address and/or diagnose at least one motor-related neurological condition. Blue-green light and green light are useful for treating motor-related neurological conditions or their symptoms. Deep red light and near infrared radiation may facilitate the repair of retinal cells and/or neurons that may be responsible for motor-related neurological conditions. Amber, orange and red light enable the early diagnosis of motor-related neurological conditions.
Light emission apparatuses emit light that is tailored to address and/or diagnose at least one motor related neurological condition. Blue green light and green light are useful for treating motor related neurological conditions or their symptoms. Deep red light and near infrared radiation may facilitate the repair of retinal cells and/or neurons that may be responsible for motor related neurological conditions. Amber, orange and red light enable the early diagnosis of motor related neurological conditions.
